article thumbnail

Bacterial vaccine shows promise as cancer immunotherapy

Science Daily: Pharmacology News

Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.

Vaccine 125
article thumbnail

New mRNA vaccine created to prevent and treat C. difficile

Science Daily: Pharmacology News

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile vaccine was found to protect against C. difficile vaccine was found to protect against C. difficile or C. In animal models, this first mRNA-LNP C.

Vaccine 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Right Time is Now to Get Your Flu Vaccine

Drugs.com

17, 2024 -- Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. The ideal time to get the flu vaccine is by the end of October, the FDA said. THURSDAY, Oct. Food and Drug Administration says.

Vaccine 111
article thumbnail

Real-World Study Confirms RSV Vaccine's Protective Power for Seniors

Drugs.com

18, 2024 -- A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization.With U.S. vaccination rates falling, "I. FRIDAY, Oct.

Vaccine 105
article thumbnail

GSK claims Moderna infringed mRNA vaccine patents

BioPharma Drive: Drug Pricing

The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.

Vaccine 109
article thumbnail

Researchers confront new US and global challenges in vaccinations of adults

Science Daily: Pharmacology News

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. and globally.

Vaccine 106
article thumbnail

Real-World Study Confirms RSV Vaccine's, Arexvy and Abrysvo, Protective Power for Seniors

Drugs.com

18, 2024 -- A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. vaccination rates falling, "I. FRIDAY, Oct.

Vaccine 98